Glenmark Life Sciences' public issue or IPO opens on Tuesday and its scrips are already attracting a premium of over 20% in the grey markets. Here are all the details you need to know:
IPO issue date: July 27 to 29
Price band: Rs 695 to Rs 720 per equity share
Min quantity/lot size: 20 stocks
Lot price: Rs 13,900 (on lower price band)
Issue size: Rs 1,500 crore
IPO listing date: August 6, 2021
Grey market premium: Rs 150
Glenmark Life Sciences is a leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.